193 related articles for article (PubMed ID: 15728649)
1. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.
Weidemann F; Breunig F; Beer M; Sandstede J; Störk S; Voelker W; Ertl G; Knoll A; Wanner C; Strotmann JM
Eur Heart J; 2005 Jun; 26(12):1221-7. PubMed ID: 15728649
[TBL] [Abstract][Full Text] [Related]
2. [Quantitative evaluation of regional myocardial function using strain and strain rate imaging: normal values in pediatric age].
Di Salvo G; Pacileo G; Rea A; Gala S; Faillace D; Verrengia M; Miele T; Castaldi B; Russo MG; Caso P; Calabrò R
Ital Heart J Suppl; 2005 Jul; 6(7):420-6. PubMed ID: 16082825
[TBL] [Abstract][Full Text] [Related]
3. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
4. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
5. Impact of right ventricular dilation on left ventricular myocardial deformation in patients after surgical repair of tetralogy of fallot.
Cheung EW; Liang XC; Lam WW; Cheung YF
Am J Cardiol; 2009 Nov; 104(9):1264-70. PubMed ID: 19840574
[TBL] [Abstract][Full Text] [Related]
6. Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease.
Krämer J; Niemann M; Liu D; Hu K; Machann W; Beer M; Wanner C; Ertl G; Weidemann F
Eur Heart J; 2013 Jun; 34(21):1587-96. PubMed ID: 23520186
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
[TBL] [Abstract][Full Text] [Related]
8. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).
Edvardsen T; Rosen BD; Pan L; Jerosch-Herold M; Lai S; Hundley WG; Sinha S; Kronmal RA; Bluemke DA; Lima JA
Am Heart J; 2006 Jan; 151(1):109-14. PubMed ID: 16368301
[TBL] [Abstract][Full Text] [Related]
9. Tei index in fabry disease.
Niemann M; Breunig F; Beer M; Hu K; Liu D; Emmert A; Herrmann S; Ertl G; Wanner C; Takenaka T; Tei C; Weidemann F
J Am Soc Echocardiogr; 2011 Sep; 24(9):1026-32. PubMed ID: 21719255
[TBL] [Abstract][Full Text] [Related]
10. Altered myocardial motion pattern in Fabry patients assessed with CMR-tagging.
Rutz AK; Juli CF; Ryf S; Widmer U; Kozerke S; Eckhardt BP; Boesiger P
J Cardiovasc Magn Reson; 2007; 9(6):891-8. PubMed ID: 18066749
[TBL] [Abstract][Full Text] [Related]
11. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
12. Use of strain and tissue velocity imaging for early detection of regional myocardial dysfunction in patients with beta thalassemia.
Hamdy AM
Eur J Echocardiogr; 2007 Mar; 8(2):102-9. PubMed ID: 16564231
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study.
Sadick N; Thomas L
Heart Lung Circ; 2007 Jun; 16(3):200-6. PubMed ID: 17452128
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular strain and strain rate in a general population.
Kuznetsova T; Herbots L; Richart T; D'hooge J; Thijs L; Fagard RH; Herregods MC; Staessen JA
Eur Heart J; 2008 Aug; 29(16):2014-23. PubMed ID: 18583396
[TBL] [Abstract][Full Text] [Related]
16. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Fabry disease.
Ries M; Gupta S; Moore DF; Sachdev V; Quirk JM; Murray GJ; Rosing DR; Robinson C; Schaefer E; Gal A; Dambrosia JM; Garman SC; Brady RO; Schiffmann R
Pediatrics; 2005 Mar; 115(3):e344-55. PubMed ID: 15713906
[TBL] [Abstract][Full Text] [Related]
18. Reference ranges for tissue Doppler measures of maternal systolic and diastolic left ventricular function.
Bamfo JE; Kametas NA; Nicolaides KH; Chambers JB
Ultrasound Obstet Gynecol; 2007 Apr; 29(4):414-20. PubMed ID: 17330924
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular radial strain impairment precedes hypertrophy in Anderson-Fabry disease.
Spinelli L; Giugliano G; Imbriaco M; Esposito G; Nappi C; Riccio E; Ponsiglione A; Pisani A; Cuocolo A; Trimarco B
Int J Cardiovasc Imaging; 2020 Aug; 36(8):1465-1476. PubMed ID: 32306159
[TBL] [Abstract][Full Text] [Related]
20. Detection of preclinical left ventricular dysfunction in Fabry disease: the contribution of tissue Doppler.
Fiuza M; Avó LB; Oliveira EI; Gonçalves S; Lopes MG
Rev Port Cardiol; 2006 Jun; 25(6):613-37. PubMed ID: 17019980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
